During the past decade, Stony Brook Dermatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Stony Brook Dermatology" are "Alopecia Areata" (1 trials), "Lymphoma, T-Cell, Cutaneous" (1 trials), "Mycosis Fungoides" (1 trials) and "Sézary Syndrome" (1 trials). Many other conditions were trialed in "Stony Brook Dermatology" in a lesser frequency.

Most popular intervention types in "Stony Brook Dermatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Naloxone Hydrochloride Lotion, 0.5%" (1 trials), "PF-06651600" (1 trials), "Placebo" (1 trials) and "Placebo Lotion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stony Brook Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Stony Brook Dermatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Stony Brook Dermatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Stony Brook Dermatology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".